1. Antiparasitic efficacy of natamycin isolated from Streptomyces gilvosporeu AXY-25 against Ichthyophthirius multifiliis
- Author
-
Xia Yanchun, Pan Xiaoyi, Zheng Cao, Shen Jinyu, Yin Wenlin, Guoqiang Mi, Cheng-Sai Zang, Ling-Yun Ling, Chun-Feng Wang, Yong-Yi Jia, Yao Jiayun, Zhi-Min Gu, and Jian-Lin Guo
- Subjects
Ichthyophthirius multifiliis ,biology ,Antiparasitic ,medicine.drug_class ,Chemical structure ,Aquatic Science ,biology.organism_classification ,Streptomyces ,In vitro ,Microbiology ,Natamycin ,In vivo ,medicine ,EC50 ,medicine.drug - Abstract
The main purpose of the present study was undertaken to isolate bioactive substances from microbial secondary metabolites of Streptomyces gilvosporeu AXY-25 and to determine their antiparasitic effect against Ichthyophthirius multifiliis. A pure compound showing strong anti- I. multifiliis activity was isolated from a culture of S. gilvosporeu AXY-25 by using the method of bioassay-guided isolation. The chemical structure of the active compound was confirmed as natamycin (NAT) by spectral analysis (EI-MS, 1H NMR and 13C NMR). An in vitro anti-parasitic assay demonstrated that 100% of theronts were killed with a concentration of 25.0 mg L−1 NAT for 4 h with an effective concentration (EC50) (95% CI) at 10.9 (10.7–11.1) mg L−1. Similiary, all tomonts were killed by a dose of 25.0 mg L−1. An in vivo anti-parasitic assay showed that the number of I. multifiliis trophonts on the surface of hybrid Erythroculter ilishaeformis in the NAT-treated group were markedly lower when compared to the control group (p
- Published
- 2019
- Full Text
- View/download PDF